Navigation Links
The Colorado Institute for Drug, Device and Diagnostic Development Announces Companies Selected From Its First Solicitation: Sophono, Inc., Receiving $600K; and PeptiVir, Inc., $300K
Date:9/27/2010

AURORA, Colo., Sept. 27 /PRNewswire/ -- The Colorado Institute for Drug, Device and Diagnostic Development (CID4) has completed the selection process from its first solicitation announced in February.  The announcement is made by Richard C. Duke, Ph.D., CID4 President/CEO, who says, "Boulder-based Sophono, Inc., is receiving $600,000 for its Alpha 1 Magnetic Bone Anchored Hearing System; and Aurora-based PeptiVir, Inc., is receiving $300,000 for its universal flu vaccine under development."

In addition to initial financial support from the state, CID4 also received federal support from Fitzsimons Redevelopment Authority via a Senate appropriation supported by Colorado Senator Michael Bennet.  Senator Bennet says, "We can strengthen our economic recovery and ensure Colorado remains a leader in innovation and entrepreneurship by supporting efforts that turn groundbreaking research into startups and companies that will grow and create good-paying jobs."

Further, Colorado Governor Bill Ritter, says: "Supporting Colorado's life sciences companies is critical to growing jobs and our economy in Colorado, and I congratulate both the CID4 for success in its first solicitation and those companies chosen to receive funding."

"Sophono's Alpha 1 has received its CE mark and is being sold in Europe.  Our investment will allow Sophono to accelerate its FDA clearance process," Kevin M. Smith, CID4 Executive Vice President/COO, explains. In addition, according to Sophono's President/CEO Jim Kasic, the company plans to relocate manufacturing and assembling operations from Germany to Boulder, resulting in the hiring of 6-10 employees. Visit http://www.sophono.com.  

PeptiVir, Inc., is an early stage biopharmaceutical company focused on the development and commercialization of a conformationally-constrained, synthetic peptide-based vaccine platform for prevention of viral diseases.
'/>"/>

SOURCE The Colorado Institute for Drug, Device and Diagnostic Development
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Colorado Cancer Research Program Will Host Golf Event to Drive the Message that Clinical Trials Play a Vital Role in the Quest to Find a Cure for Cancer
2. American Lung Association in Colorados Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver
3. Denver-Ft. Collins Ophthalmologist First in Colorado to Implant nanoFLEX Lens
4. Colorado MRI Clinic Blends Ultra Patient Care with Significant Cost Savings
5. Colorado-Based Spectranetics Corporation to Pay $5 Million to Resolve Allegations Relating to its Medical Devices
6. Forensic Laboratories Selected for Colorado Companies to Watch Award
7. CO-REC Ready to Assist Colorado Health Care Providers in Implementing Electronic Health Record Systems and Achieving Meaningful Use
8. Tahoma, Colorado Springs and Salt Lake City Have the Highest Percentage of HIV Patients in the U.S. Who Are Left Untreated
9. Tacoma, Colorado Springs and Salt Lake City Have the Highest Percentage of HIV Patients in the U.S. Who Are Left Untreated
10. AlloSource Named Colorados Top Healthcare Company
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Genetics, Inc. (NASDAQ: ATOS ), The Breast Health ... Chief Financial Officer & General Counsel, will present at the ... 2013, in New York City at ... is scheduled to begin at 3:30 p.m. EDT and will ... go to www.atossagenetics.com . For more information ...
(Date:5/17/2013)... NATICK, Mass. , May 17, 2013  Boston ... to participate at the annual EuroPCR Scientific Program May ... "We are pleased to present a particularly rich and ... Keith Dawkins , M.D., global chief ... several trials will be presented, including the NG PROMUS ...
(Date:5/16/2013)... , May 16, 2013  Nektar Therapeutics, (Nasdaq: ... W. Robin , is scheduled to present at the ... York at the Sheraton New York Hotel on ... The presentation will be accessible via a Webcast through ... of the Nektar website: http://www.nektar.com . This Webcast will ...
Breaking Medicine Technology:Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
... ERBITUX (cetuximab), the,first approved IgG1 monoclonal antibody ... and commercialized by,ImClone Systems Incorporated, was the ... at the recently concluded 43rd Annual Meeting,of ... This year's ASCO ERBITUX presentations showcased the ...
... attack,comparable to two widely used diabetes medicines , ... June 6, 2007 - A study,of more than 33,000 type ... study shows that the incidence of,hospitaliations for heart attack, and/or ... Avandia is the,same as for other diabetes treatments. The ...
Cached Medicine Technology:Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 2Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 3Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 4Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 5Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 6Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 7Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 8Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 9Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 10Newly Published Data from Large Study Support Cardiovascular Safety,of Avandia (Rosiglitazone Maleate) 2Newly Published Data from Large Study Support Cardiovascular Safety,of Avandia (Rosiglitazone Maleate) 3Newly Published Data from Large Study Support Cardiovascular Safety,of Avandia (Rosiglitazone Maleate) 4
(Date:5/18/2013)... SATURDAY, May 18 (HealthDay News) -- Children who swallow ... to remove the objects, according to a new study. ... Center in New Orleans, found that more than 79 ... required either surgery or an endoscopic procedure, in which ... digestive tract. Only 21 percent of these cases can ...
(Date:5/18/2013)... published an original art book for iPad with tango as ... who share their creations based on the traditional music genre ... iPad . , This work gathers more than 150 ... signature idiosyncrasy and passion of tango. Such book is ... it includes a free trailer of the book for readers ...
(Date:5/18/2013)... 2013) There are significant cost and risk ... diagnose or treat gastrointestinal problems, according to research ... A study by New York Presbyterian Hospital and ... may substantially reduce the cost and risk of ... believed to affect nearly 25 percent of adults, ...
(Date:5/18/2013)... In a May 14, 2013 article entitled ... Discovering Cancer Gene,” Fox News reported the movie star ... she carried a gene that doctors estimated gave her ... 50 percent risk of ovarian cancer (go to: goo.gl/5JHBP). ... 2013 with a blog post entitled “A Patient’s Journey: ...
(Date:5/18/2013)... A ground-breaking advance in colonoscopy technology signals ... presented today at Digestive Disease Week (DDW). Additional ... for colonoscopies and exploring safer methods for removing ... a device called a colonoscope to examine the ... a doctor to look for precancerous polyps called ...
Breaking Medicine News(10 mins):Health News:Swallowing Magnets Can Be Fatal for Children 2Health News:New Art Book for iPad: Tango Art 2Health News:New research identifies practice changes to improve value and quality of GI procedures 2Health News:Angelina Jolie – Scarless Breast Augmentation Surgery 2Health News:New colonoscope provides ground-breaking view of colon 2Health News:New colonoscope provides ground-breaking view of colon 3Health News:New colonoscope provides ground-breaking view of colon 4
... Stockholm, Sweden: Melanoma of the eye (ocular or uveal melanoma) ... there is no effective treatment and patients die within an ... ten patients live for a year. Now, final results from ... significantly extends the time patients can live without the disease ...
... People,s bodies build up vitamin D through exposure to sunlight, ... areas of the United States with low sunlight are more ... in the same places. The researchers say the findings ... study shows that across-the-board vitamin D recommendations just won,t work ...
... FRIDAY, Sept. 23 (HealthDay News) -- Foreign-born U.S. women are ... cancer, but native-born women still outpace them, a new study ... mammography among foreign-born women in the United States, but there ... their use of recommended breast cancer screening," study lead researcher ...
... disabilities increased in the U.S. among non-elderly adults during ... Mojtabai, MD, PhD, of the Johns Hopkins Bloomberg School ... found the prevalence of disability attributed to other chronic ... remained unchanged. The findings will appear in the November ...
... A little motivation for parents could go a long ... their own care, a Wayne State University researcher believes. ... in WSU,s School of Medicine, has received a two-year, ... Digestive and Kidney Diseases of the National Institutes of ...
... News) -- Many people who undergo MRI scans describe feeling ... and a new study may explain why. Researchers ... on fluid circulating in the inner ear, impacting balance and ... , In the study, published online Sept. 22 in ...
Cached Medicine News:Health News:Infusing chemotherapy into the liver gives extra months of disease-free life in melanoma patients 2Health News:Infusing chemotherapy into the liver gives extra months of disease-free life in melanoma patients 3Health News:Infusing chemotherapy into the liver gives extra months of disease-free life in melanoma patients 4Health News:Many Black Men in Cold Climates Lack Vitamin D 2Health News:Wayne State University study aims to improve diabetes management in high-risk youth 2Health News:Wayne State University study aims to improve diabetes management in high-risk youth 3Health News:Magnetic Field May Cause MRI-Induced Vertigo 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: